Polycystic ovary syndrome and pregnancy;Síndrome de ovario poliquístico y embarazo

Revista Medica de Chile

Volumn 140, Issue 7, 2012, Pages 919-925

  Sir Petermann, Teresa ^a   De Guevara, Amanda Ladrón ^a   Villarroel, Ana Claudia ^b   Preisler, Jessica ^a   Echiburú, Búrbara ^a,d   Recabarren, Sergio ^c  

^a Unidad de Endocrinología   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CONCEPCIÓN   (Chile)

^d Ingeniero en Biotecnología Molecular   (Chile)

Author keywords

Birth weight; Diabetes gestational; Polycystic ovary syndrome; Pregnancy complications

Indexed keywords

ANIMAL; ANIMAL MODEL; BIRTH WEIGHT; FEMALE; FETUS; HUMAN; MALE; OVARY POLYCYSTIC DISEASE; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRENATAL DEVELOPMENT; REVIEW;

ANIMALS; BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; FETUS; HUMANS; MALE; MODELS, ANIMAL; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84868318426     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872012000700015     Document Type: Review

References (40)

1. Knochenhauer ES, Key TJ, Kashsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 71: 3078-82.
2. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84: 1897-9.
3. Crisosto N, Codner E, Maliqueo M, Echiburú B, Sánchez F, Cassorla F, et al. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 2739-43.
4. Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann N Y Acad Sci 2006; 1092: 158-74.
5. Sir-Petermann T, Maliqueo M, Codner E, Echiburú B, Crisosto N, Pérez V, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 4637-42.
6. Sir-Petermann T, Codner E, Pérez V, Echiburú B, Maliqueo M, Ladrón de Guevara AH, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94: 1923-30.
7. Fulghesu AM, Villa P, Pavone V, Guido M, Apa R, Caruso A, et al. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 644-8.
8. Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries. J Clin Endocrinol Metab 1994; 79: 1158-65.
9. Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988; 123: 733-9.
10. Piltonen T, Koivunen R, Ruokonen A, Tapanainen JS. Ovarian age-related responsiveness to human chorionic gonadotropin. J Clin Endocrinol Metab 2003; 88: 3327-32.
11. Hughesdon PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". Obstet Gynecol Surv 1982; 37: 59-77.
12. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, et al. Formation and early development of follicles in the polycystic ovary. Lancet 2003; 362: 1017-21.
13. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intraovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod 2004; 10: 107-17.
14. Takayama K, Fukaya T, Sasano H, Funayama Y, Susuki T, Takaya R, et al. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum Reprod 1996; 11: 1387-92.
15. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen J. Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005; 20: 1820-6.
16. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, et al. Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition. J Clin Endocrinol Metab 2008; 93: 3478-83.
17. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 165: 1667-72.
18. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 71: 1256S-61S.
19. Xita N, Tsatsoulis A. Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical and Genetic Association Studies. J Clin Endocrinol Metab 2006; 91: 1660-6.
20. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002; 26: 883-96.
21. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Pérez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002; 17: 2573-9.
22. Sir-Petermann T, Hitschfeld C, Codner E, Maliqueo M, Ávila A, Echiburú B, et al. Gonadal function in low birth weight infants. J Pediatr Endocrinol Metab 2007; 20: 405-14.
23. Benítez R, Sir-Petermann T, Palomino A, Angel B, Maliqueo M, Pérez F, et al. Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico. Rev Med Chile 2001; 129: 707-12.
24. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburú B, Gacitúa R, et al. Birth weight in offspring of mothers with polycystic ovary syndrome. Hum Reprod 2005; 20: 2122-6.
25. Padmanabhan V, Manikkam M, Recabarren S, Foster D. Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female. Mol Cell Endocrinol 2006; 246: 165-74.
26. Abbott DH, Tarantal AF, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol 2009; 71: 776-84.
27. Sir-Petermann T, Devoto L, Maliqueo M, Peirano P, Recabarren SE, Wildt L. Resumption of ovarian function during lactational amenorrhoea in breastfeeding women with polycystic ovary syndrome: endocrine aspects. Hum Reprod 2001; 16: 1603-10.
28. Sir-Petermann T, Echiburú B, Maliqueo M, Crisosto N, Sánchez F, Hitschfeld C, et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 2007; 22: 1830-6.
29. Villarroel AC, Echiburú B, Riesco V, Maliqueo M, Cárcamo M, Hitschfeld C, et al. Síndrome de ovario poliquístico (SOP) y embarazo: Experiencia clínica. Rev Med Chile 2007; 135: 1530-1538.
30. Recabarren SE, Sir-Petermann T, Rios R, Maliqueo M, Echiburú B, Smith R, et al. Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood. J Clin Endocrinol Metab 2008; 93: 3318-24.
31. Sir-Petermann T, Codner E, Maliqueo M, Echiburú B, Hitschfeld C, Crisosto N, et al. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 3105-9.
32. Recabarren SE, Smith R, Ríos R, Maliqueo M, Echiburú B, Codner E, et al. Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 1820-6.
33. Recabarren SE, Padmanabhan V, Codner E, Lobos A, Durán C, Vidal M, et al. Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab 2005; 289: E801-6.
34. Recabarren SE, Lobos A, Figueroa Y, Padmanabhan V, Foster DL, Sir-Petermann T. Prenatal testosterone treatment alters LH and testosterone responsiveness to GnRH agonist in male sheep. Biol Res 2007; 40: 329-38.
35. Recabarren SE, Rojas-García PP, Recabarren MP, Alfaro VH, Smith R, Padmanabhan V, et al. Prenatal testosterone excess reduces sperm count and motility. Endocrinology 2008; 149: 6444-8.
36. Altieri P, Gambineri A, Prontera O, Cionci G, Franchina M, Pasquali R. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010; 149: 31-6.
37. Goldenberg N, Glueck C. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation. Minerva Ginecol 2008; 60: 63-75.
38. De Leo V, Musacchio MC, Piomboni P, Di Sabatino A, Morgante G. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol 2011; 157: 63-6.
39. Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004; 19: 1323-30.
40. Crisosto N, Echiburú B, Maliqueo M, Pérez V, de Guevara AL, Preisler J, et al. Improvement of hyperan-drogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters. Fertil Steril 2012; 97: 218-24.